RAD001 Plus Bevacizumab in Metastatic Melanoma

Clinical trial NCT00591734 · COMPLETED

Trial details

NCT number: NCT00591734
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2008-01-01
Primary completion: 2010-10-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.